Seasonal allergic rhinitis

British Medical Journal

Volumn 314, Issue 7091, 1997, Pages 1392-1395

  Parikh, Abhi ^a   Scadding, Glenis K ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; IPRATROPIUM BROMIDE; TERFENADINE;

ALLERGIC RHINITIS; ATOPY; CLINICAL FEATURE; HEART ARRHYTHMIA; HUMAN; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; SENSITIZATION; SHORT SURVEY;

ADULT; ANTI-ALLERGIC AGENTS; HUMANS; IMMUNOTHERAPY; PATIENT EDUCATION; PREVALENCE; RHINITIS, ALLERGIC, SEASONAL;

EID: 0031001248     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Emanuel M. Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy 1988;18:295-304.
2. Smith J. Epidemiology. In: Mygind N, Naclerio RM, eds. Allergic and non-allergic rhinitis: clinical aspects. 1st ed. Copenhagen: Munksgaard, 1993:15-21.
3. Sibbald B. Epidemiology of allergic rhinitis. In: Burr M, ed. Monograph on epidemiology of allergic disease. Basel: SKarger, 1993:61-79.
4. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994;73:35-9.
5. McSharry C. Oilseed rape sensitivity. Clin Exp Allergy 1997;27:125-7.
6. Kay AB. Mechanisms and treatment of allergic rhinitis. In: Mackay I, Bull TR. eds. Rhinology. 5th ed. London: Butterworths, 1987: 93-114. (Vol 4 of: Kerr AG, ed. Scott-Brown's Otolaryngotogy.)
7. Kay AB. Mechanisms and treatment of allergic rhinitis. In: Mackay I, Bull TR. eds. Rhinology. 5th ed. London: Butterworths, 1987: 93-114. (Vol 4 of: Kerr AG, ed. Scott-Brown's Otolaryngotogy.)
8. Emberlin J. Plant allergens on pauci-micronic airborne particles. Clin Exp Allergy 1995;25:202-5.
9. Sibbald B, Strachan DP. Epidemiology of rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Scientific, 1995: 32-43.
10. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989;19:59-63.
11. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ 1987;294:279-83.
12. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren. BMJ 1992;304:873-5.
13. Hagy GW, Settipane GA. Bronchial asthma, allergic rhinitis and allergy skin tests among college students. J Allergy 1969;44:323-32.
14. Strachan DP. Epidemiology of hay fever: towards a community diagnosis. Clin Exp Allergy 1995;25:296-303.
15. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992;98:279-85.
16. Barbee R, Kaltenborn W, Lebowitz M, Burrows B. Longitudinal changes in allergen skin test reactivity in a community population sample. J Allergy Clin Immunol 1987;79:16-24.
17. Sibbald B, Rink E, D'Souza M. Is atopy increasing? Br J Gen Pract 1990;40:338-40.
18. Ishizaka I, Koizumi K, Ikemori R, Ishiyama V, Kushibiki E. Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ann Allergy 1987;58:265-70.
19. Takafuji S, Suzuki S, Muranaka M, Miyamoto T. Influence of environmental factors on IgE production. In: Chadwick D, Whelan J, eds. IgE, mast cells and allergic response. Chichester: John Wiley and Sons, 1989: 199-203.
20. Bousquet J, Vignola AM, Campbell AM, Michel FB. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996;110:207-18.
21. Scadding GK. Allergic rhinitis. In: Scadding GK, ed. Immunology of ENT disorders. Dordrecht: Kluwer Academic Press, 1994.
22. Andersson M, Greiff L, Svensson C, Wollmer P, Persson CGA. Allergic and nonallergic rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Scientific, 1995: 145-51.
23. Wang D, Clement P, Smitz J, Derde MP Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolaryngol (Stockh) 1994;114:552-5.
24. Naclerio RM, Meier H, Kagey-Sobotka A, Akinson NF Jr, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
25. Gerrard J, Vickers P, Gerrard C. The familial incidence of allergic disease. Ann Allergy 1976;36:10-5.
26. Vuurman EFPM, van Veggel L, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-6.
27. Scadding GK. Rhinitis medicamentosa [editorial]. Clin Exp Allergy 1995;25:391-4.
28. Dixon CMS, Barnes PJ. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1989;27:831-6.
29. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
30. Creticos P. Allergic rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Scientific, 1995: 1394-414.
31. Bahmer FA. Topical levocabastine - an effective alternative to oral antihistamine in seasonal allergic rhinoconjunctivitis. Clin Exp Allergy 1995;25:220-7.
32. Mackowiak JI. Fluticasone propionate aqueous nasal spray improves rhinitis quality of life and reduces lost labour costs. Ann Allergy 1994;72:99.
33. Konig P. Inhaled corticosteroids - their present and future role in the management of asthma. J Allergy Clin Immunol 1988;82:297-306.
34. Bousquet J, Michel FB. Specific immunotherapy in allergic rhinitis and asthma. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Scientific, 1995: 1309-24.
35. Bousquet J, Maasch HJ, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind placebo controlled immunotherapy with mixed grass pollen allergoids. II: Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-46.
36. Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Michel FB, et al. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. II: Efficacy of a double-blind, placebo controlled, specific immunotherapy with standardised extracts. J Allergy Clin Immunol 1991;88:43-53.
37. Thompson RA, Bousquet J, Cohen S, Frei PC, Jager L., Lambert PH, et al. Allergen specific immunotherapy. Report of a WHO-IUIS working group. Lancet 1989;i:259-61.
38. Weeke B, Mosbech H, Engel T, Malling HJ, Basomba A, Bousquet J, et al. Specific immunotherapy. Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 1988;43 (suppl 6):1-33.
39. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.